Since the isolation of BRCA1, the familial breast/ovarian cancer predisposition gene, much effort has been invested in characterizing the mutation spectrum. The large size of the gene and the wide distribution of its more than 100 mutations has increased the challenge of this endeavor such that trad
Testing for BRCA1 mutations: a cost-effectiveness analysis
✍ Scribed by Sevilla, Christine; Moatti, Jean-Paul; Julian-Reynier, Claire; Eisinger, François; Stoppa-Lyonnet, Dominique; Bressac-de Paillerets, Brigitte; Sobol, Hagay
- Book ID
- 110025275
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 115 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1018-4813
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A model creates the framework for a cost-e!ectiveness analysis, allowing decision makers to explore the implications of using an intervention in di!erent ways and under di!erent conditions. To serve its purpose a model must produce accurate predictions and allow for substantial variation in the fact
The identification of genetic mutations linked to breast cancer has made it possible to test for the genetic predisposition to this disease. However, though this test may provide certain benefits, there are also potential risks involved with the testing process, including social and economic conside